Clincosm LogoSign in Get a demo

cervical carcinoma

Showing 26 - 50 of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Carcinoma Trial in La Jolla (Intensity Modulated Radiation Therapy (IMRT), Cisplatin, Gemcitabine)

Completed
  • Cervical Carcinoma
  • Intensity Modulated Radiation Therapy (IMRT)
  • +2 more
  • La Jolla, California
    Moores UC San Diego Cancer Center
Feb 16, 2022

Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)

Recruiting
  • Head and Neck Cancer
  • +6 more
  • Recombinant L-IFN adenovirus injection
  • Shanghai, Shanghai, China
    Shanghai Fengxian District Central Hospital
Jan 16, 2022

Cervical Carcinoma, Human Papillomavirus Infection Trial in United States (other, procedure, behavioral)

Recruiting
  • Cervical Carcinoma
  • Human Papillomavirus Infection
  • Best Practice
  • +5 more
  • Lexington, Kentucky
  • +3 more
Jan 31, 2022

Prognostic Value of Protein IMP3 Expression in Cervical Cancer

Active, not recruiting
  • Cervical Carcinoma
  • immunohistochemical analysis with murine monoclonal antihuman antibodies IMP3
  • (no location specified)
Jan 5, 2022

Solid Tumor, Adult, NSCLC, Urothelial Carcinoma Trial (BA3071, Nivolumab)

Not yet recruiting
  • Solid Tumor, Adult
  • +8 more
  • BA3071
  • Nivolumab
  • (no location specified)
Jan 5, 2022

Pelvic Health, Sexual Function, and Quality of Life in Pelvic

Recruiting
  • Anal Carcinoma
  • +6 more
  • Pelvic Examination
  • Survey
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 1, 2021

Cervical Carcinoma Trial in Guangzhou (CCRT+TIL)

Active, not recruiting
  • Cervical Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Nov 13, 2021

Women Undergoing Pelvic Surgery for Treatment of Gynecologic

Recruiting
  • Cervical Carcinoma
  • +4 more
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2021

Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®

Recruiting
  • Melanoma (Excluding Uveal Melanoma)
  • +15 more
  • XmAb®23104
  • Yervoy® (ipilimumab)
  • San Diego, California
  • +15 more
Sep 20, 2021

Solid Tumor, Triple-negative Breast Cancer, Gastric Adenocarcinoma Trial in Houston, Chuo-Ku (LY3435151, Pembrolizumab)

Terminated
Has Results
  • Solid Tumor
  • +8 more
  • Houston, Texas
  • +1 more
Aug 4, 2021

Ovarian Carcinoma, Endometrial Carcinoma, Cervical Carcinoma Trial in Belgium, Denmark (Selinexor)

Completed
Has Results
  • Ovarian Carcinoma
  • +2 more
  • Leuven, Belgium
  • +3 more
Jan 13, 2021

Cervical Carcinoma Trial in Philadelphia (Culturally appropriate intervention, General health education control)

Completed
Has Results
  • Cervical Carcinoma
  • Culturally appropriate intervention
  • General health education control
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 9, 2021

CATCH-UP Intervention in Increasing Cancer Screening and

Completed
  • Breast Carcinoma
  • +5 more
  • Informational Intervention
  • Portland, Oregon
    OHSU Knight Cancer Institute
Aug 17, 2020

Atypical Squamous Cell of Undetermined Significance, Cervical Carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3 Trial in

Completed
  • Atypical Squamous Cell of Undetermined Significance
  • +6 more
  • Cervical Papanicolaou Test
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Jul 29, 2020

Cervical Cancer Trial in Houston, Toronto, Québec (Cisplatin, Carboplatin, Paclitaxel)

Not yet recruiting
  • Cervical Carcinoma
  • Cervical Cancer
  • Paclitaxel, SUB09583MIG
  • (no location specified)
Jul 20, 2020

Cervical Carcinoma, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma Trial run by the NCI (Ixempra (Ixabepilone

Terminated
Has Results
  • Cervical Carcinoma
  • +3 more
  • Ixempra (Ixabepilone (BMS-247550) )
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 13, 2019

Cervical Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Bronx (Palliative Therapy, Palliative Therapy +

Completed
  • Cervical Carcinoma
  • +9 more
  • Palliative Therapy
  • Palliative Therapy + idiographic
  • Bronx, New York
    Albert Einstein College of Medicine
Sep 13, 2019

Cervical Carcinoma, Cervical Dysplasia Trial (SMS text)

Unknown status
  • Cervical Carcinoma
  • Cervical Dysplasia
  • SMS text
  • (no location specified)
Jun 4, 2019

Cervical Carcinoma, Cervical Dysplasia Trial in London (Neutral text message reminder, Messenger text message reminder, Social

Completed
  • Cervical Carcinoma
  • Cervical Dysplasia
  • Neutral text message reminder
  • +5 more
  • London, United Kingdom
    Department of Surgery and Cancer, St Mary's Campus, Praed Street
Oct 23, 2018

Renal Cell Carcinoma, Colorectal Adenocarcinoma, Non-squamous NSCLC Trial in Birmingham (Nintedanib, Bevacizumab)

Completed
  • Renal Cell Carcinoma
  • +4 more
  • Birmingham, Alabama
    University of Alabama at Birmingham Comprehensive Cancer Center
Jul 9, 2018

Cervical Carcinoma, Ovarian Carcinoma, Uterine Corpus Cancer Trial in Duarte (Supportive Care, Quality-of-Life Assessment,

Terminated
  • Cervical Carcinoma
  • +4 more
  • Supportive Care
  • +2 more
  • Duarte, California
    City of Hope Medical Center
May 4, 2018

Cervical Carcinoma, Human Papillomavirus Infection Trial in Columbus (Disease Screening, Educational Intervention, Informational

Completed
  • Cervical Carcinoma
  • Human Papillomavirus Infection
  • Disease Screening
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 7, 2018

Cervical Carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3, Stage 0 Cervical Cancer Trial in United States (Celecoxib,

Completed
Has Results
  • Cervical Carcinoma
  • +2 more
  • Tucson, Arizona
  • +42 more
Sep 13, 2017

Cervical Carcinoma Trial in Nanning (Endostar, DDP)

Unknown status
  • Cervical Carcinoma
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Mar 16, 2017

Cervical Carcinoma Trial in Guangzhou (interventional therapy)

Completed
  • Cervical Carcinoma
  • interventional therapy
  • Guangzhou, Guangdong, China
    Central laboratory in Fuda cancer hospital
Aug 26, 2016